Neuroepidemiology

Journal

Publication Venue For

  • Incidence and Case Fatality at the County Level as Contributors to Geographic Disparities in Stroke Mortality.  47:96-102. 2016
  • Premature Atrial Contractions on the Screening Electrocardiogram and Risk of Ischemic Stroke: The Reasons for Geographic and Racial Differences in Stroke Study.  47:53-58. 2016
  • Phenotyping Stroke in Sub-Saharan Africa: Stroke Investigative Research and Education Network (SIREN) Phenomics Protocol.  45:73-82. 2015
  • Racial and geographic differences in prevalence, awareness, treatment and control of dyslipidemia: The reasons for geographic and racial differences in stroke (REGARDS) study.  37:39-44. 2011
  • Physical activity and self-reported cardiovascular comorbidities in persons with multiple sclerosis: Evidence from a cross-sectional analysis.  36:183-191. 2011
  • Sensitivity and specificity of stroke symptom questions to detect stroke or transient ischemic attack.  36:100-104. 2011
  • Smokers with multiple sclerosis are more likely to report comorbid autoimmune diseases.  36:85-90. 2011
  • Geographic variation in one-year recurrent ischemic stroke rates for elderly medicare beneficiaries in the USA.  34:123-129. 2010
  • Racial differences in parkinson's disease medication use in the reasons for geographic and racial differences in stroke cohort: A cross-sectional study.  33:329-334. 2009
  • Smoking status over two years in patients with multiple sclerosis.  32:72-79. 2008
  • Exposure to the US stroke buckle as a risk factor for cerebrovascular mortality.  30:229-233. 2008
  • Clock drawing phenotypes in community-dwelling African Americans and Caucasians: Results from the University of Alabama at Birmingham study of aging.  28:175-180. 2007
  • Obtaining medical records from healthcare facilities under the HIPAA privacy rule: The experience of a national longitudinal cohort study.  28:162-168. 2007
  • The changing risk factor profile of participants enrolled in a secondary stroke prevention trial: Vitamin intervention for stroke prevention.  27:222-229. 2006
  • Plasma total homocysteine levels in stroke patients screened for the vitamin intervention for stroke prevention clinical trial in the era of folate fortification.  26:45-51. 2005
  • The reasons for geographic and racial differences in stroke study: Objectives and design.  25:135-143. 2005
  • Clinical research in primary stroke prevention: Needs, opportunities, and challenges.  25:91-104. 2005
  • The confounding of race and geography: How much of the excess stroke mortality among African Americans is explained by geography?.  23:118-122. 2004
  • Association between statin use and Alzheimer's disease.  23:94-98. 2004
  • Vitamin intervention for stroke prevention (VISP) trial: Rationale and design.  20:16-25. 2001
  • Relationship of hospitalized stroke rate and in-hospital mortality to the decline in US stroke mortality.  10:251-259. 1991

    • International Standard Serial Number (issn)

  • 0251-5350

    • Electronic International Standard Serial Number (eissn)

  • 1423-0208